trans
FlexNovo
trans
contact
impressum
legal notice
print this page
BioSolveIT
The Premier Scientific Solution Provider
advantages of using FlexNovo
trans
Fragment-based design of compounds or libraries by docking large fragment- or combinatorial chemistry spaces in the context of the active site
trans
Fragment growing: Evolution of fragments into the depth of the active site
trans
Identification of novel scaffolds, lead prototypes and alternative binding modes for a given target
trans
Filtering based on physicochemical and geometric properties and solution list diversity criteria
Our KnowledgeSpace and FlexNovo were used to design starting points for novel CDK2 inhibitors in the pocket of Indirubin5-Sulphonate: two selected and high ranking solutions are shown. PoseView was used to create the 2D images (visible on mouse-over). Click image for a full-size view.
details
FlexNovo is a new molecular design program based on the FlexX-technology of incrementally constructing a ligand in an active site. It facilitates a fragment-based approach to de novo design in the context of the 3D-structure of the target.
  1. Fragment spaces consist of sets of molecular fragments that have specific 'link atoms' as open valences. Different 'link types' represent different chemical environments. A set of rules determines which link types are compatible (i.e. can be connected). Fragment spaces can be focused libraries derived from known binders or general fragment collections with link-rules. A space with only 16 000 fragments easily spans a chemical space of about 1018 virtual compounds of reasonable size, thus covering a considerable part of the 'chemical universe'.
  2. The FlexNovo algorithm is based on the incremental construction procedure as implemented in FlexX. In a first step FlexNovo places all available fragments. It takes the best scoring fragments entering the following steps during which compatible fragments are successively added to the so far obtained set of placements. All available scoring functions known from FlexX can be used for ranking the (intermediate) results. Additionally, FlexNovo considers a multitude of physicochemical property, geometry and diversity filter criteria. For the initial placement step, it also evaluates the compliance with pharmacophore-type constraints as known from FlexX-Pharm.
  3. In a first feasibility study, FlexNovo has been used to design potential inhibitors for four targets of pharmaceutical interest: dihydrofolate reductase, cyclin-dependant kinase 2, cyclooxygenase-2 and estrogen receptor. For each of these targets solution sets were generated that consist of up to 50 de novo molecules. All of the sets contained chemically reasonable structures that have similar structural motifs when compared to known active structures. The solutions also mimic the corresponding binding orientations. Additionally, the distribution of a number of physicochemical properties within such a set is reasonable and similar compared to distributions obtained from sets of known active structures.
FlexNovo is meant to be an integrated and user-customizable idea-generating system. It suggests new structural motifs, designing libraries of lead-prototypes and in proposing novel scaffolds as well as alternative binding modes for a target protein.
It also facilitates the evolution of a ligand in the depth of the active site, if one starts e.g. from a fragment obtained in a crystal structure screen.
The software can be even more powerful if there is expert knowledge integrated, for example, considering key interactions with the target, specific chemical motifs or certain physicochemical properties.
complementary software
Fragment spaces as input for FlexNovo can be generated by CoLibri, BioSolveITs library design toolkit. Additionally, pre-defined fragment spaces derived from vendor compound collections can be obtained from BioSolveIT upon request. For similarity-based de novo design FTrees-FS is the method of choice.

FlexX's intuitive and easy to use GUI can be used to prepare the active site of the protein. This can then be readily imported into FlexNovo.

application examples
trans
Generation of CDK2 inhibitor prototypes
FlexNovo was utilized to search through our KnowledgeSpace for novel CDK2 inhibitor prototype candidates, based on the active site of Indirubin-5-sulphonate (1E9H). Presentation at 237th ACS Meeting, Salt Lake City
trans
A Fragment-Growing exercise with Thrombin
Starting with the Prolin-Ring underneath the loop around TYR60, a well-known fragment-binding motiv for Thrombin, we successfully searched the entire KnowledgeSpace for suitable protocols to grow de novo ligands within this active site. Presentation at the Gordon Research Conference on Computer Aided Drug Design, Tilton
download
operating system version download date size FlexIDGen licenses support
Linux x86 32bit 1.6.3
tar.gz
11.01.2012 10.8 MB
2.2.0
eval
order
support
Linux x86 64bit 1.6.3
tar.gz
11.01.2012 10.7 MB
2.0.0
eval
order
support
Microsoft Windows 32bit 1.6.3
exe
11.01.2012 7.4 MB
2.2.0
eval
order
support
additional material
user guide
pdf
16.12.2011 2 MB also included in the package

Visualization of the input and the results is possible through our popular viewer FlexV:

operating system version download date size FlexIDGen licenses support
Linux x86 32bit 1.9.0
tar.gz
08.12.2008 2.4 MB
2.2.0
support
Linux x86 64bit 1.9.0
tar.gz
08.12.2008 2.4 MB
2.0.0
support

Last modified Thursday, 02. Feb 2012 23:17 CET by WebMaster